Showing results (301-310 of 586) with videos related to
Sort By:
Pageof 59
Journal of the American Society of Nephrology : JASN|August 26, 2003
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery diseaseDonal N Reddan, Lynda Anne Szczech, Robert H Tuttle, et al.American Heart Journal|June 25, 2005
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationaleRobert P Giugliano, L Kristin Newby, Robert A Harrington, et al.The American Journal of Cardiology|November 26, 2008
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)Jonathan P Piccini, Patrick M Hranitzky, Rakhi Kilaru, et al.The Journal of Thoracic and Cardiovascular Surgery|November 26, 2008
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgeryRajendra H Mehta, Gail E Hafley, C Michael Gibson, et al.The American Journal of Cardiology|September 6, 2018
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure StatusAndrew P Ambrosy, Lukasz P Cerbin, Marat Fudim, et al.American Heart Journal|March 29, 2008
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialRachel E Anderson, Marc A Pfeffer, Jens Jakob Thune, et al.American Heart Journal|August 9, 2005
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trialE Magnus Ohman, Frans Van de Werf, Elliott M Antman, et al.European Heart Journal|January 18, 2006
Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomesAndrés Orlandini, Rafael Díaz, Daniel Wojdyla, et al.Journal of Cardiac Failure|October 18, 2008
High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomizationLarry A Allen, Joseph G Rogers, J Wayne Warnica, et al.Critical Pathways in Cardiology|September 4, 2009
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH RegistryAmit Kumar, Gregg C Fonarow, Kim A Eagle, et al.Pageof 59